To study the effect of Thyroidinum 3X as an Interventional medicine for Paediatric Hypothyroidism
Phase 4
- Conditions
- Health Condition 1: E039- Hypothyroidism, unspecified
- Registration Number
- CTRI/2024/02/062939
- Lead Sponsor
- Apparna Ilankumaran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients within the Paediatric age group 1-18 years of age.
Patients of both sexes.
Patients diagnosed with Clinical and Subclinical Hypothyroidism
Patients with a TSH level below 20mUI/ml
Exclusion Criteria
Patients with congenital and autoimmune thyroid disorders
Patients with other systemic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Paediatric Hypothyroidism is one of the areas of increasing concern in the present-day <br/ ><br>generation. With various other research being conducted in the area of hypothyroidism, the <br/ ><br>Homoeopathic method of treatment serves to be one of the safer and gentler methods for the <br/ ><br>restoration of health. The outcomes of this study pave way for the further research to be done <br/ ><br>and also help us to identify the validity of the use of Thyroidinum 3 X in such cases.Timepoint: General follow up every month, with TDT review every 3 months
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil